Related Experiment Videos
The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled
D C Musch1, P R Lichter, K E Guire
1Department of Ophthalmology, The University of Michigan, Ann Arbor 48105, USA.
Ophthalmology
|April 14, 1999
Summary
The Collaborative Initial Glaucoma Treatment Study (CIGTS) compared initial glaucoma medications versus surgery for open-angle glaucoma. Findings will guide optimal initial treatment strategies for patients.
Area of Science:
- Ophthalmology
- Clinical Trials
Background:
- Open-angle glaucoma requires effective initial treatment strategies.
- The choice between medication and surgery impacts patient outcomes and quality of life.
Purpose of the Study:
- To compare the efficacy of initial medical treatment versus immediate filtration surgery for newly diagnosed open-angle glaucoma.
- To evaluate the impact of treatment on visual field loss, intraocular pressure, visual acuity, and health-related quality of life.
Main Methods:
- Randomized, controlled clinical trial involving 607 patients.
- Patients were randomized to either a stepped medication regimen (n=307) or trabeculectomy surgery (n=300).
- Primary outcome was visual field loss progression; secondary outcomes included quality of life, visual acuity, and intraocular pressure.
Main Results:
- The study enrolled a diverse population, with 55% males and 38.1% Black individuals.
- Most participants (90.6%) had primary open-angle glaucoma.
- Randomization ensured balanced demographic and clinical characteristics between treatment groups.
Conclusions:
- The Collaborative Initial Glaucoma Treatment Study provides comprehensive data on initial open-angle glaucoma management.
- Results will inform clinical decisions by integrating ophthalmic measures with patient-reported quality of life outcomes.